South Africa's Aspen H1 profit inches up


JOHANNESBURG, March 4 (Reuters) - South African drugmaker Aspen Pharmacare APNJ.J on Monday reported a 1% rise in half-year profit, aided by the lower net financing costs.

For the six months ended December, Aspen recorded a normalised headline earnings per share of 688.3 cents, slightly up from 679.6 cents a year earlier.

(Reporting by Nqobile Dludla, Editing by Louise Heavens)

((; +27103461066;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.